Safety and Efficacy of Chronic Extended Release Cornstarch Therapy for Glycogen Storage Disease Type I

Background: Glycogen storage disease type I (GSD I) causes severe hypoglycemia during periods of fasting since both glycogenolysis and gluconeogenesis are impaired. Primary treatment in North America consists of cornstarch therapy every 3–4 h. Waxy maize extended release cornstarch was introduced fo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JIMD Rep
Main Authors: Ross, Katalin M., Brown, Laurie M., Corrado, Michelle M., Chengsupanimit, Tayoot, Curry, Latravia M., Ferrecchia, Iris A., Porras, Laura Y., Mathew, Justin T., Weinstein, David A.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4864714/
https://ncbi.nlm.nih.gov/pubmed/26303612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2015_488
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados